Todd Bobick

Todd Bobick is an experienced clinical quality assurance professional currently serving as Vice President of Clinical Quality Assurance at BridgeBio since September 2019, where responsibilities include leading Clinical Quality Assurance functions, implementing strategies, and ensuring compliance with regulations. Previously, Todd held positions such as Director of Quality Assurance at Sierra Oncology and Associate Director of Clinical QA at StemCells, Inc., with a focus on establishing QA functions and leading GCP compliance initiatives. Todd's career spans over two decades, with roles at prominent organizations including Onyx Pharmaceuticals and Genentech, emphasizing audit strategy development, regulatory inspection preparation, and training. Todd holds a Master of Science from the University of Alberta and a Bachelor of Science from the University of Calgary.